The All-in-One Screener can be used to find insider buys and sells over the last week by clicking on the Insiders tab and changing the settings for All Insider Buying to “$1,000,000+” and duration to "May 2016” and “May 2016.”
According to the above filters, the following are recent buys and sells from company insiders in the past week.
Kwok Fong Wong, director of BIO-key International Inc. (BKYI), bought 565,712 shares in the company at 23 cents per share on June 7. Since then, the price of the stock has risen by 4.3% to 24 cents.
The company has an insider ownership of 4.56% and institutional ownership of 0.32%. It develops and markets fingerprint identification biometric technology and software solutions and cryptographic authentication-transaction security technologies as well as related identity management and credentialing software solutions.
During the last 12 months, the price of the stock has risen by 9% and is now trading with a P/B ratio of 0.94. The price is 4% below its 52-week high and 140% above its 52-week low.
Train Fund Management LP, director of Sysco Corp. (SYY), bought 693,000 shares in the company at $48.8 per share on June 6. Since then, the price of the stock has dropped by 0.2% to $48.68.
The company through its subsidiaries and divisions is engaged in the distribution of food and related products to the foodservice or food-away-from-home industry.
During the last 12 months, the price of the stock has risen by 31% and is now trading with a P/B ratio of 9.96. The price is 3.95% below its 52-week high and 37.32% above its 52-week low.
Kevin M. Donlon, president of US Geothermal Inc. (HTM), bought 596,756 shares at 80 cents per share on June 6. Since then, the price of the stock has risen by 6.2% to 85 cents.
The company has an insider ownership of 4.50% and institutional ownership of 25.68%. It is a renewable energy company engaged in the development, production and sale of electricity from geothermal energy.
During the last 12 months, the price of the stock has risen by 60% and is now trading with a P/B ratio of 0.91. The price is 2.30% below its 52-week high and 77.08% above its 52-week low.
Braslyn Ltd., 10% owner of William Lyon Homes Inc. (WLH), bought 208,000 shares in the company at $16.39 per share on June 7. Since then, the price of the stock has risen by 4.2% to $17.08.
The company along with its subsidiaries designs, constructs and sells single-family detached and attached homes in California, Arizona, Nevada, Colorado, Washington and Oregon. Its segments are California, Arizona, Nevada, Colorado, Washington and Oregon.
During the last 12 months, the price of the stock has dropped by 30% and is now trading with a P/B ratio of 0.81. The price is 35.23% below its 52-week high and 124.44% above its 52-week low.
Most important sales of the week
Min Fang, director, and WP X Biologic LLC, director and 10% owner, sold 5,550,000 shares of China Biologic Products Inc. (CBPO) at $111 per share on June 8. Since then, the price of the stock has risen by 5.7% to $117.36.
The company has an insider ownership of 52.26% and institutional ownership of 70.11%. It is a biopharmaceutical company that is engaged in the research, development, manufacturing and sales of plasma-based pharmaceutical products to hospitals and inoculation centers directly or through distributors in China.
During the last 12 months, the price of the stock has risen by 12% and is now trading with a P/B ratio of 7.54. The price is 18.66% below its 52-week high and 45.61% above its 52-week low.
Lal Family Partners LP, 10% owner of The Estee Lauder Companies Inc. (EL), sold 600,000 shares in the company at $93.19 per share on June 7. Since then, the price of the stock has dropped by 0.3% to $92.88.
The company has an institutional ownership of 51.72% and insider ownership of 0.21%. It is engaged in the manufacturing and marketing of skin care, makeup, fragrance and hair care products.
During the last 12 months, the price of the stock has dropped by 0.5% and is now trading with a P/B ratio of 8.97. The price is 4.72% below its 52-week high and 26.08% above its 52-week low.
Joerg C. Laukien, director and 10% owner of Bruker Corp. (BRKR), sold 2 million shares in the company at $25.65 per share on June 6. Since then, the price of the stock has risen by 1.9% to $26.13.
The company has an institutional ownership of 61.65% and insider ownership of 61.13%. It is designer and manufacturer of life science and materials research systems in life science research, pharmaceuticals, applied markets, nanotechnology, cell biology, clinical research, microbiology and in-vitro diagnostics industries
During the last 12 months, the price of the stock has risen by 28% and is now trading with a P/B ratio of 6.07. The price is 12.46% below its 52-week high and 65.59% above its 52-week low.
Rehan Jaffer, 10% owner of Mirati Therapeutics Inc. (MRTX), sold 999,358 shares in the company at the price of $9.41 per share on June 9. Since then, the price of the stock has risen by 2.2% to $9.62.
The company has an institutional ownership of 75.54% and insider ownership of 0.40%. It is a biopharmaceutical company that discovers, develops and commercializes novel therapeutics with an initial focus on cancer and infectious diseases.
During the last 12 months, the price of the stock has dropped by 69% and is now trading with a P/B ratio of 1.85. The price is 81.50% below its 52-week high and 5.60% above its 52-week low.
Start a free seven-day trial of Premium Membership to GuruFocus.
